Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker

Published on July 16, 2026

Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in the once-fringe area of psychedelic medicine.

Continue reading on website
Other news

SK Hynix Makes Its U.S. Debut: Which ETFs Offer Exposure?

July 16, 2026
Friday, July 10, may have been ordinary for those outside the investment community, but for folks engaged with the market, it marked an opportunity to gain exposure to the second most valuable company in South Korea. On Friday, SK Hynix (SKHY) became available to U.S. investors via the Nasdaq.

Do Fiscal Rules Work?

July 16, 2026
General Douglas MacArthur once remarked that “rules are mostly made to be broken.” He was at odds with U.S. President Harry Truman over the conduct of the Korean War, feeling that the restrictions placed on his forces weren’t supportive of success.